Literature DB >> 6581807

1 alpha,25-dihydroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes.

H Tanaka, E Abe, C Miyaura, Y Shiina, T Suda.   

Abstract

The differentiating action of 1 alpha,25-dihydroxyvitamin D3 [1 alpha, 25-(OH)2D3] in hematopoietic cells was examined in 3 tumor cell lines. 1 alpha,25-(OH)2D3 induced common differentiation-associated properties in macrophages and granulocytes similarly in mouse myeloblastic leukemia cells (M1), human promyelocytic leukemia cells (HL-60) and human histiocytic monoblast-like lymphoma cells (U937). 1 alpha,25(OH)2D3 markedly induced alpha-naphthyl acetate esterase activity, a typical marker of monocyte-macrophages, in M1 and HL-60 cells. In HL-60 and U937 cells, the vitamin also induced binding of the monoclonal antibody MAS 072, specific for monocyte-macrophages, but not of MAS 067, specific for granulocytes. These results clearly indicate that 1 alpha, 25(OH)2D3 induces differentiation of all cell lines examined preferentially along the monocyte-macrophage pathway.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6581807     DOI: 10.1016/0006-291x(83)91544-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Streptococcus gordonii promotes rapid differentiation of monocytes into dendritic cells through interaction with the sialic acid-binding adhesin.

Authors:  Yumiko Urano-Tashiro; Ayako Yajima; Yukihiro Takahashi; Kiyoshi Konishi
Journal:  Odontology       Date:  2011-10-18       Impact factor: 2.634

2.  Induction of cyclo-oxygenase synthesis in human promyelocytic leukaemia (HL-60) cells during monocytic or granulocytic differentiation.

Authors:  A Honda; A Raz; P Needleman
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

3.  Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures.

Authors:  N Takahashi; T Kukita; B R MacDonald; A Bird; G R Mundy; L M McManus; M Miller; A Boyde; S J Jones; G D Roodman
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 4.  The rise and fall of central dogmas.

Authors:  George Klein; Eva Klein
Journal:  Oncoimmunology       Date:  2016-09-26       Impact factor: 8.110

Review 5.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Comparison of the mechanisms of bone resorption induced by 1 alpha,25-dihydroxyvitamin D3 and lipopolysaccharides.

Authors:  Y Shiina; A Yamaguchi; H Yamana; E Abe; S Yoshiki; T Suda
Journal:  Calcif Tissue Int       Date:  1986-07       Impact factor: 4.333

7.  Induction of (2'-5') oligoadenylate synthetase activity during granulocyte and monocyte differentiation.

Authors:  D Ferbus; U Testa; M Titeux; F Louache; M N Thang
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

8.  Transforming growth factor-beta 1 modulates the effect of 1 alpha, 25-dihydroxyvitamin D3 on leukemic cells.

Authors:  M Morikawa; N Harada; G Soma; T Yoshida
Journal:  In Vitro Cell Dev Biol       Date:  1990-07

9.  Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line.

Authors:  M G Thomas; S Tebbutt; R C Williamson
Journal:  Gut       Date:  1992-12       Impact factor: 23.059

10.  1α,25(OH)(2)-Vitamin D3 increases dysferlin expression in vitro and in a human clinical trial.

Authors:  Noemi De Luna; Jordi Díaz-Manera; Carmen Paradas; Cristina Iturriaga; Ricardo Rojas-García; Josefa Araque; Mireia Genebriera; Ignasi Gich; Isabel Illa; Eduard Gallardo
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.